Tokyo, March 3 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060793) titled 'Multicenter Collaborative Study on Biomarker Analysis Using Circulating Tumor DNA in Resectable Solid Tumors' on March 2.
Study Type:
Observational
Primary Sponsor:
Institute - National Cancer Center Hospital East
Condition:
Condition - Clinical stage I-IV resectable solid tumors planned to be treated with definitive therapy
Classification by malignancy - Malignancy
Genomic information - YES
Objective:
Narrative objectives1 - This study aims to identify biomarkers reflecting the molecular biological nature of resectable solid tumors by performing comprehensive molecular profiling of blood and tumor tissue specim...